Research Institute of Dallas

Dallas, Texas 75231

Use our guide to learn which trials are right for you!

We've found
11 trials
at this facility
Type 1 Diabetes Mellitus Clinical Trial
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Status: Enrolling
Updated: 1/3/2013
mi
from
Dallas, TX
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling, Phase III
Updated: 3/10/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Status: Enrolling, Phase II
Updated: 3/2/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiovascular Disease Clinical Trial
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Diabetes Clinical Trial
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
Status: Enrolling, Phase III
Updated: 2/25/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Status: Enrolling
Updated: 10/22/2012
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiovascular Disease Clinical Trial
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling, Phase II
Updated: 2/10/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Diabetes Mellitus Clinical Trial
Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes
Status: Enrolling, Phase IV
Updated: 3/14/2016
mi
from
Dallas, TX
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Status: Enrolling
Updated: 4/30/2012
mi
from
Dallas, TX
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Status: Enrolling, Phase III
Updated: 12/2/2015
mi
from
Dallas, TX
Click here to add this to my saved trials